SARS corona virus peptides recognized by antibodies in the sera of convalescent cases - PubMed (original) (raw)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

Jian-Ping Guo et al. Virology. 2004.

Abstract

We synthesized on cellulose membranes 4942 ten-amino-acid peptides which included all of the sequences predicted for the severe acute respiratory syndrome (SARS) corona virus. We probed these membranes with four pairs of acute and convalescent sera from recovered SARS cases. We correlated positively reacting peptides with the in vitro SARS-CoV neutralizing activity of the samples. We found that convalescent sera with high neutralizing activity recognized exclusively only a limited number of peptides on the membranes. This suggests that antibodies against the epitopes represented by these peptides could be responsible for much of the SARS-CoV neutralizing activity. The findings have implications for monitoring humoral responses to SARS-CoV as well as for developing a successful SARS vaccine.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

(a) Outline of the overlapping peptide set covering membranes M1, M2, M3, and M4. Panels on the membranes are designated from left to right P1, P2, P3, and P4. Numbers in the boxes designate the location of each open reading frame. The note to the right of M4P1 shows the key to the Orfs with peptide totals in brackets. This membrane was spotted with dye instead of amino acids. In actual membranes, each spot is a 10-amino-acid peptide with adjacent spots being shifted by two amino acids. Characterization of the immune response against these single case epitopes promises to provide important insights into their role in the resolution of infection. However, epitopes recognized by multiple convalescent sera may be the most important targets of neutralizing antibodies. (b–d) Examples of membrane panels probed with various serum samples and developed with peroxidase-labeled goat antihuman IgA; (b) M1P2 probed with control serum, acute as well as convalescent serum from case 2, convalescent serum from case 1, and serum from the deceased case. Notice the triad of spots recognized only in the serum of the two convalescent cases. The peptide sequences from Orf 1a are SDDYIKLNGP, DYIKLNGPLT, and IKLNGPLTVG. (c) P3M2 probed with acute and chronic serum from case 2 and serum from the deceased case. Panel 3 has peptides from S-protein. Notice the triad of spots recognized only by the convalescent serum. The peptide sequences from S-protein are FQPFQQFGRD, PFQQFGRDVS, and QQFGRDVSDF. (d) P4M3 probed with acute and convalescent serum from case 2 and convalescent serum from case 1. Notice the triad of spots recognized in the two convalescent sera. The peptide sequences from N-protein are QLPQGTTLPK, PQGTTLPKGF, and GTTLPKGFYA.

Fig. 2

Fig. 2

(a) Vero E6 cells were imaged before infection and (b) 32 h after infection with SARS-CoV at a multiplicity of 1 pfu per cell. Notice the extensive cell damage in b.

Similar articles

Cited by

References

    1. DeGroot A.S. How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past. Vaccine. 2003;21:4095–4104. - PMC - PubMed
    1. Kuo L., Godeke G.J., Raamsman M.J., Masters P.S., Rottier P.J. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J. Virol. 2000;74:1393–1406. - PMC - PubMed
    1. Li W., Moore M.J., Vasllleva N., Sul J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzurlaga K., Greenough T.C., Choe N., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. - PMC - PubMed
    1. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–1404. - PubMed
    1. Martina B.E.E., Hagmans B.L., Kuiken T., Fouchier R.A.M., Rimmelzwaan G.F., Amerongen G.V., Peiris J.S.M., Lim W., Osterhaus A.D.M.E. SARS virus infection of cats and ferrets. Nature. 2003;425:815. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources